Form 4 for BLTE BELITE BIO, INC
Accepted 2026-06-22 06:05:45 ET · period of report 2026-06-18 · accession 0001193125-26-276615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-22 06:05 | 2026-06-18 | BLTE | Scholl Hendrik Peter | Chief Medical Off | S - Sale | $145.24 | -10.0K | 15.0K | -40% | -$1.45M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American depositary share | 2026-06-18 | S | D | 96 | $143.90 | 24,904 | I By Bioptima Ltd. | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. |
| 2 | Common | American depositary share | 2026-06-18 | S | D | 3,748 | $144.66 | 21,156 | I By Bioptima Ltd. | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) Represents the weighted average price of shares sold at prices that ranged from $144.07 to $144.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 3 | Common | American depositary share | 2026-06-18 | S | D | 4,861 | $145.43 | 16,295 | I By Bioptima Ltd. | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F3) Represents the weighted average price of shares sold at prices that ranged from $145 to $145.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 4 | Common | American depositary share | 2026-06-18 | S | D | 1,199 | $146.24 | 15,096 | I By Bioptima Ltd. | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F4) Represents the weighted average price of shares sold at prices that ranged from $146.005 to $146.755. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 5 | Common | American depositary share | 2026-06-18 | S | D | 96 | $147.11 | 15,000 | I By Bioptima Ltd. | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. |